Dr. Joseph Eid is a physician, board certified in Medical Oncology, Hematology, and Internal Medicine. He joined BMS in 2017 as Senior Vice President and Head of Medical.
Before joining BMS, Joe worked at Merck in Oncology Clinical Research, and in this capacity he was the team leader for Pembrolizumab (anti-PD-1 antibody) from first in man trial leading to registration.
Prior to joining Merck, Joe was at Roche Pharmaceuticals in Oncology Clinical Research.
Joe received his medical degree from St. Joseph University School of Medicine in Beirut, Lebanon. He completed his fellowship in hematology and medical oncology at Rutgers-Robert Wood Johnson Medical School (RWJMS). He was recruited to the faculty at RWJMS and appointed Assistant Professor of Medicine and Pathology, Departments of Medicine and Pathology and Laboratory Medicine. Joe is a licensed physician in New Jersey and continues to attend a weekly, half-day clinic at RWJMS.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October